Phage therapy as an alternative or complementary strategy to prevent and control biofilm-related infections

Current Opinion in Microbiology

Volumn 39, Issue , 2017, Pages 48-56

  Pires, D P ^a   Melo, L D R ^a   Vilas Boas, D ^a   Sillankorva, S ^a   Azeredo, J ^a  

^a UNIVERSITY OF MINHO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEFOTAXIME; CHLORINE; CIPROFLOXACIN;

ALTERNATIVE MEDICINE; ANTIBIOTIC SENSITIVITY; BACTERIAL CELL; BACTERIAL CLEARANCE; BACTERIOPHAGE; BIOFILM; BIOFILM RELATED INFECTION; DEBRIDEMENT; DRUG EFFICACY; ENTEROBACTERIA PHAGE T4; ESCHERICHIA COLI INFECTION; GENETIC MANIPULATION; HOST RESISTANCE; INFECTION; INFECTION CONTROL; INFECTION PREVENTION; KLEBSIELLA PNEUMONIAE; NONHUMAN; PHAGE THERAPY; PROTEUS MIRABILIS PHAGE; PSEUDOMONAS AERUGINOSA PHAGE; QUORUM SENSING; REVIEW; RNA PHAGE; STAPHYLOCOCCUS AUREUS; ANIMAL; BACTERIAL INFECTION; DISEASE MODEL; HUMAN; MOUSE; PIG; WOUND INFECTION;

ANIMALS; BACTERIAL INFECTIONS; BIOFILMS; DISEASE MODELS, ANIMAL; HUMANS; MICE; PHAGE THERAPY; SWINE; WOUND INFECTION;

EID: 85030161052     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2017.09.004     Document Type: Review

References (73)

1. Flemming, H.-C., Wingender, J., Szewzyk, U., Steinberg, P., Rice, S.A., Kjelleberg, S., Biofilms: an emergent form of bacterial life. Nat Rev Microbiol 14 (2016), 563–575.
2. Lehman, S.M., Donlan, R.M., Bacteriophage-mediated control of a two-species biofilm formed by microorganisms causing catheter-associated urinary tract infections in an in vitro urinary catheter model. Antimicrob Agents Chemother 59 (2015), 1127–1137.
3. Gutiérrez, D., Vandenheuvel, D., Martínez, B., Rodríguez, A., Lavigne, R., García, P., Two phages, phiIPLA-RODI and phiIPLA-C1C, lyse mono- and dual-species Staphylococcal biofilms. Appl Environ Microbiol 81 (2015), 3336–3348.
4. Azeredo, J., Sutherland, I.W., The use of phages for the removal of infectious biofilms. Curr Pharm Biotechnol 9 (2008), 261–266.
5. Sillankorva, S., Azeredo, J., The use of bacteriophages and bacteriophage-derived enzymes for clinically relevant biofilm control. Borysowski, J., Międzybrodzki, R., Górski, A., (eds.) Phage Therapy: Current Research and Applications, 2014.
6. Abedon, S.T., Thinking about microcolonies as phage targets. Bacteriophage 2 (2012), 200–204.
7. Donlan, R.M., Preventing biofilms of clinically relevant organisms using bacteriophage. Trends Microbiol 17 (2009), 66–72.
8. Harper, D., Parracho, H., Walker, J., Sharp, R., Hughes, G., Werthén, M., Lehman, S., Morales, S., Bacteriophages and Biofilms. Antibiotics 3 (2014), 270–284.
9. Alves, D.R., Gaudion, A., Bean, J.E., Perez Esteban, P., Arnot, T.C., Harper, D.R., Kot, W., Hansen, L.H., Enright, M.C., Jenkins, A.T.A., Combined use of bacteriophage K and a novel bacteriophage to reduce Staphylococcus aureus biofilm formation. Appl Environ Microbiol 80 (2014), 6694–6703.
10. Fu, W., Forster, T., Mayer, O., Curtin, J.J., Lehman, S.M., Donlan, R.M., Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system. Antimicrob Agents Chemother 54 (2010), 397–404.
11. Alves, D.R., Perez-Esteban, P., Kot, W., Bean, J.E., Arnot, T., Hansen, L.H., Enright, M.C., Jenkins, A.T.A., A novel bacteriophage cocktail reduces and disperses Pseudomonas aeruginosa biofilms under static and flow conditions. Microb Biotechnol 9 (2015), 61–74.
12. Alemayehu, D., Casey, P.G., McAuliffe, O., Guinane, C.M., Martin, J.G., Shanahan, F., Coffey, A., Ross, R.P., Hill, C., Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells. MBio, 3, 2012 e00029-12.
13. Pires, D.P., Dötsch, A., Anderson, E.M., Hao, Y., Khursigara, C.M., Lam, J.S., Sillankorva, S., Azeredo, J., A genotypic analysis of five P. aeruginosa strains after biofilm infection by phages targeting different cell surface receptors. Front Microbiol, 8, 2017, 1229 In this study the authors followed the progression of bacteriophage insensitive mutants in a biofilm infected by phages targeting diferent cell receptors.
14. Flemming, H.-C., Wingender, J., The biofilm matrix. Nat Rev Microbiol 8 (2010), 623–633.
15. Romaní, A.M., Fund, K., Artigas, J., Schwartz, T., Sabater, S., Obst, U., Relevance of polymeric matrix enzymes during biofilm formation. Microb Ecol 56 (2008), 427–436.
16. Drulis-Kawa, Z., Majkowska-Skrobek, G., Maciejewska, B., Bacteriophages and phage-derived proteins – application approaches. Curr Med Chem 22 (2015), 1757–1773.
17. Rakhuba, D.V., Kolomiets, E.I., Szwajcer Dey, E., Novik, G.I., Bacteriophage receptors, mechanisms of phage adsorption and penetration into host cell. Pol J Microbiol 59 (2010), 145–155.
18. Hu, J., Miyanaga, K., Tanji, Y., Diffusion properties of bacteriophages through agarose gel membrane. Biotechnol Prog 26 (2010), 1213–1221.
19. Pamp, S.J., Sternberg, C., Tolker-Nielsen, T., Insight into the microbial multicellular lifestyle via flow-cell technology and confocal microscopy. Cytometry Part A 75A (2009), 90–103.
20. Vilas Boas, D., Almeida, C., Sillankorva, S., Nicolau, A., Azeredo, J., Azevedo, N.F., Discrimination of bacteriophage infected cells using locked nucleic acid fluorescent in situ hybridization (LNA-FISH). Biofouling 32 (2016), 179–190 This work studied the progression of phage infected cells within the biofilm using LNA probes.
21. Storms, Z.J., Brown, T., Cooper, D.G., Sauvageau, D., Leask, R.L., Impact of the cell life-cycle on bacteriophage T4 infection. FEMS Microbiol Lett 353 (2014), 63–68.
22. Mah, T.F., O'Toole, G.A., Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 9 (2001), 34–39.
23. Łoś, M., Golec, P., Łoś, J.M., Weglewska-Jurkiewicz, A., Czyz, A., Wegrzyn, A., Wegrzyn, G., Neubauer, P., Effective inhibition of lytic development of bacteriophages lambda, P1 and T4 by starvation of their host, Escherichia coli. BMC Biotechnol, 7, 2007, 13.
24. Bryan, D., El-Shibiny, A., Hobbs, Z., Porter, J., Kutter, E.M., Bacteriophage T4 infection of stationary phase E. coli: life after log from a phage perspective. Front Microbiol, 7, 2016, 1391 This paper thoroughly describes the patterns of T4 phage infection of stationary-phase cells. The authors identified a new ‘hibernation’ mode of long-term interaction.
25. Sillankorva, S., Oliveira, R., Vieira, M.J., Sutherland, I., Azeredo, J., Pseudomonas fluorescens infection by bacteriophage Φs1: The influence of temperature, host growth phase and media. FEMS Microbiol Lett 241 (2004), 13–20.
26. Jamal, M., Hussain, T., Das, C.R., Andleeb, S., Characterization of Siphoviridae phage Z and studying its efficacy against multidrug-resistant Klebsiella pneumoniae planktonic cells and biofilm. J Med Microbiol 64 (2015), 454–462.
27. Cerca, N., Oliveira, R., Azeredo, J., Susceptibility of Staphylococcus epidermidis planktonic cells and biofilms to the lytic action of Staphylococcus bacteriophage K. Lett Appl Microbiol 45 (2007), 313–317.
28. Wood, T.K., Knabel, S.J., Kwan, B.W., Bacterial persister cell formation and dormancy. Appl Environ Microbiol 79 (2013), 7116–7121.
29. Shapiro, J.A., Nguyen, V.L., Chamberlain, N.R., Evidence for persisters in Staphylococcus epidermidis RP62a planktonic cultures and biofilms. J Med Microbiol 60 (2011), 950–960.
30. Labrie, S.J., Samson, J.E., Moineau, S., Bacteriophage resistance mechanisms. Nat Rev Microbiol 8 (2010), 317–327.
31. Pires, D., Sillankorva, S., Faustino, A., Azeredo, J., Use of newly isolated phages for control of Pseudomonas aeruginosa PAO1 and ATCC 10145 biofilms. Res Microbiol 162 (2011), 798–806.
32. Hosseinidoust, Z., Tufenkji, N., van de Ven, T.G.M., Predation in homogeneous and heterogeneous phage environments affects virulence determinants of Pseudomonas aeruginosa. Appl Environ Microbiol 79 (2013), 2862–2871.
33. Le, S., Yao, X., Lu, S., Tan, Y., Rao, X., Li, M., Jin, X., Wang, J., Zhao, Y., Wu, N.C., et al. Chromosomal DNA deletion confers phage resistance to Pseudomonas aeruginosa. Sci Rep, 4, 2014, 4738.
34. Lacqua, A., Wanner, O., Colangelo, T., Martinotti, M.G., Landini, P., Emergence of biofilm-forming subpopulations upon exposure of Escherichia coli to environmental bacteriophages. Appl Environ Microbiol 72 (2006), 956–959.
35. Zhang, J., Örmälä-Odegrip, A.-M., Mappes, J., Laakso, J., Top-down effects of a lytic bacteriophage and protozoa on bacteria in aqueous and biofilm phases. Ecol Evol 4 (2014), 4444–4453.
36. Oechslin, F., Piccardi, P., Mancini, S., Gabard, J., Moreillon, P., Entenza, J.M., Resch, G., Que, Y.-A., Synergistic interaction between phage therapy and antibiotics clears Pseudomonas aeruginosa infection in endocarditis and reduces virulence. J Infect Dis, 2016, 10.1093/infdis/jiw632.
37. Moyano, A.J., Tobares, R.A., Rizzi, Y.S., Krapp, A.R., Mondotte, J.A., Bocco, J.L., Saleh, M.-C., Carrillo, N., Smania, A.M., A long-chain flavodoxin protects Pseudomonas aeruginosa from oxidative stress and host bacterial clearance. PLoS Genet, 10, 2014, e1004163.
38. Poole, K., Bacterial stress responses as determinants of antimicrobial resistance. J Antimicrob Chemother 67 (2012), 2069–2089.
39. Papenfort, K., Bassler, B.L., Quorum sensing signal-response systems in Gram-negative bacteria. Nat Rev Microbiol 14 (2016), 576–588.
40. Høyland-Kroghsbo, N.M., Maerkedahl, R.B., Svenningsen, S.L., A quorum-sensing-induced bacteriophage defense mechanism. MBio 4 (2013), e00362–e412.
41. Tan, D., Svenningsen, S.L., Middelboe, M., Quorum sensing determines the choice of antiphage defense strategy in Vibrio anguillarum. MBio, 6, 2015, e00627.
42. Qin, X., Sun, Q., Yang, B., Pan, X., He, Y., Yang, H., Quorum sensing influences phage infection efficiency via affecting cell population and physiological state. J Basic Microbiol 57 (2017), 162–170.
43. Ryan, E.M., Alkawareek, M.Y., Donnelly, R.F., Gilmore, B.F., Synergistic phage–antibiotic combinations for the control of Escherichia coli biofilms in vitro. FEMS Immunol Med Microbiol 65 (2012), 395–398.
44. Bedi, M.S., Verma, V., Chhibber, S., Amoxicillin and specific bacteriophage can be used together for eradication of biofilm of Klebsiella pneumoniae B5055. World J Microbiol Biotechnol 25 (2009), 1145–1151.
45. Verma, V., Harjai, K., Chhibber, S., Restricting ciprofloxacin-induced resistant variant formation in biofilm of Klebsiella pneumoniae B5055 by complementary bacteriophage treatment. J Antimicrob Chemother 64 (2009), 1212–1218.
46. Rahman, M., Kim, S., Kim, S.M., Seol, S.Y., Kim, J., Characterization of induced Staphylococcus aureus bacteriophage SAP-26 and its anti-biofilm activity with rifampicin. Biofouling 27 (2011), 1087–1093.
47. Coulter, L.B., McLean, R.J.C., Rohde, R.E., Aron, G.M., Effect of bacteriophage infection in combination with tobramycin on the emergence of resistance in Escherichia coli and Pseudomonas aeruginosa biofilms. Viruses 6 (2014), 3778–3786.
48. Zhang, Y., Hu, Z., Combined treatment of Pseudomonas aeruginosa biofilms with bacteriophages and chlorine. Biotechnol Bioeng 110 (2013), 286–295.
49. Melo, L.D.R., Veiga, P., Cerca, N., Kropinski, A.M., Almeida, C., Azeredo, J., Sillankorva, S., Development of a phage cocktail to control Proteus mirabilis catheter-associated urinary tract infections. Front Microbiol, 7, 2016, 1024.
50. Nzakizwanayo, J., Hanin, A., Alves, D.R., McCutcheon, B., Dedi, C., Salvage, J., Knox, K., Stewart, B., Metcalfe, A., Clark, J., et al. Bacteriophage can prevent encrustation and blockage of urinary catheters by Proteus mirabilis. Antimicrob Agents Chemother 60 (2015), 1530–1536.
51. Kelly, D., McAuliffe, O., Ross, R.P., Coffey, A., Prevention of Staphylococcus aureus biofilm formation and reduction in established biofilm density using a combination of phage K and modified derivatives. Lett Appl Microbiol 54 (2012), 286–291.
52. Lu, T.K., Collins, J.J., Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy. Proc Natl Acad Sci U S A 106 (2009), 4629–4634.
53. Lu, T.K., Collins, J.J., Dispersing biofilms with engineered enzymatic bacteriophage. Proc Natl Acad Sci U S A 104 (2007), 11197–11202.
54. Pei, R., Lamas-Samanamud, G.R., Inhibition of biofilm formation by T7 bacteriophages producing quorum-quenching enzymes. Appl Environ Microbiol 80 (2014), 5340–5348.
55. Seth, A.K., Geringer, M.R., Nguyen, K.T., Agnew, S.P., Dumanian, Z., Galiano, R.D., Leung, K.P., Mustoe, T.A., Hong, S.J., Bacteriophage therapy for Staphylococcus aureus biofilm-infected wounds: a new approach to chronic wound care. Plast Reconstr Surg 131 (2013), 225–234.
56. Mendes, J.J., Leandro, C., Corte-Real, S., Barbosa, R., Cavaco-Silva, P., Melo-Cristino, J., Górski, A., Garcia, M., Wound healing potential of topical bacteriophage therapy on diabetic cutaneous wounds. Wound Repair Regen 21 (2013), 595–603.
57. Kamal, F., Dennis, J.J., Burkholderia cepacia complex Phage-Antibiotic Synergy (PAS): antibiotics stimulate lytic phage activity. Appl Environ Microbiol 81 (2015), 1132–1138.
58. Torres-Barceló, C., Hochberg, M.E., Evolutionary rationale for phages as complements of antibiotics. Trends Microbiol 24 (2016), 249–256 A comprehensive review about the combination of phages and antibiotics.
59. Chaudhry, W.N., Concepción-Acevedo, J., Park, T., Andleeb, S., Bull, J.J., Levin, B.R., Synergy and order effects of antibiotics and phages in killing pseudomonas aeruginosa biofilms. PLOS ONE, 12, 2017, e0168615 This paper studied the potential of combinations of phages and antibiotics for the treatment of P. aeruginosa biofilms, highlighting the order effects of the combined therapy.
60. Hughes, K.A., Sutherland, I.W., Jones, M.V., Biofilm susceptibility to bacteriophage attack: the role of phage-borne polysaccharide depolymerase. Microbiology 144 (1998), 3039–3047.
61. Yan, J., Mao, J., Mao, J., Xie, J., Bacteriophage polysaccharide depolymerases and biomedical applications. BioDrugs 28 (2014), 265–274.
62. Scholl, D., Rogers, S., Adhya, S., Merril, C.R., Bacteriophage K1-5 encodes two different tail fiber proteins, allowing it to infect and replicate on both K1 and K5 strains of Escherichia coli. J Virol 75 (2001), 2509–2515.
63. Glonti, T., Chanishvili, N., Taylor, P.W., Bacteriophage-derived enzyme that depolymerizes the alginic acid capsule associated with cystic fibrosis isolates of Pseudomonas aeruginosa. J Appl Microbiol 108 (2010), 695–702.
64. Lin, T.-L., Hsieh, P.-F., Huang, Y.-T., Lee, W.-C., Tsai, Y.-T., Su, P.-A., Pan, Y.-J., Hsu, C.-R., Wu, M.-C., Wang, J.-T., Isolation of a bacteriophage and its depolymerase specific for K1 capsule of Klebsiella pneumoniae: implication in typing and treatment. J Infect Dis 210 (2014), 1734–1744.
65. Pan, Y.-J., Lin, T.-L., Chen, C.-C., Tsai, Y.-T., Cheng, Y.-H., Chen, Y.-Y., Hsieh, P.-F., Lin, Y.-T., Wang, J.-T., Klebsiella phage ΦK64-1 encodes multiple depolymerases for multiple host capsular types. J Virol, 91, 2017, 10.1128/JVI.02457-16 In this paper eight novel capsule depolymerases where identified in a multihost Klebisiella phage.
66. Cornelissen, A., Ceyssens, P.-J., T'Syen, J., Van Praet, H., Noben, J.-P., Shaburova, O.V., Krylov, V.N., Volckaert, G., Lavigne, R., The T7-related Pseudomonas putida phage φ15 displays virion-associated biofilm degradation properties. PLoS ONE, 6, 2011, e18597.
67. Cornelissen, A., Ceyssens, P.-J., Krylov, V.N., Noben, J.-P., Volckaert, G., Lavigne, R., Identification of EPS-degrading activity within the tail spikes of the novel Pseudomonas putida phage AF. Virology 434 (2012), 251–256.
68. Majkowska-Skrobek, G., Łątka, A., Berisio, R., Maciejewska, B., Squeglia, F., Romano, M., Lavigne, R., Struve, C., Drulis-Kawa, Z., Capsule-targeting depolymerase, derived from Klebsiella KP36 phage, as a tool for the development of anti-virulent strategy. Viruses, 8, 2016, 324.
69. Gutiérrez, D., Briers, Y., Rodríguez-Rubio, L., Martínez, B., Rodríguez, A., Lavigne, R., García, P., Role of the pre-neck appendage protein (Dpo7) from phage vB_SepiS-phiIPLA7 as an anti-biofilm agent in Staphylococcal species. Front Microbiol, 6, 2015, 1315.
70. Chan, B.K., Abedon, S.T., Loc-Carrillo, C., Phage cocktails and the future of phage therapy. Future Microbiol 8 (2013), 769–783.
71. Mendes, J.J., Leandro, C., Mottola, C., Barbosa, R., Silva, F.A., Oliveira, M., Vilela, C.L., Melo-Cristino, J., Gorski, A., Pimentel, M., et al. In vitro design of a novel lytic bacteriophage cocktail with therapeutic potential against organisms causing diabetic foot infections. J Med Microbiol 63 (2014), 1055–1065.
72. Drilling, A., Morales, S., Jardeleza, C., Vreugde, S., Speck, P., Wormald, P.-J., Bacteriophage reduces biofilm of Staphylococcus aureus ex vivo isolates from chronic rhinosinusitis patients. Am J Rhinol Allergy 28 (2014), 3–11.
73. Schmerer, M., Molineux, I.J., Ally, D., Tyerman, J., Cecchini, N., Bull, J.J., Challenges in predicting the evolutionary maintenance of a phage transgene. J Biol Eng, 8, 2014, 21.